GCG’s Q2 2024 Healthcare Industry Update provides an overview of the latest trends in the sector, including recent performance, valuation multiples, and the state of the middle-market M&A environment.

Key findings include the following:

• Public equities across the Healthcare industry experienced modest returns in Q2 2024. As inflation continues to decelerate, interest rate cuts are anticipated to take place in the second half of 2024. These cuts are expected to create a more favorable economic environment for public equity markets and bolster economic growth for smaller companies.
• Deal volume remained relatively stable in the Healthcare sector during Q2 2024 compared to Q1 2024. While deal volume remained stable, the average deal value saw a significant rebound, likely due to several large transactions in the Pharmaceutical and Facilities sectors.
• Based on a representative set of publicly traded companies in the Healthcare industry, public companies traded at an average multiple of 15.5x EBITDA and 3.1x revenue in Q2 2024.

Click here for the full update.

See here for all Healthcare News and Updates

Get in Touch

Tell us a little about yourself and we will get in touch as soon as we can.